Literature DB >> 11669456

Characterization of ochratoxin A transport by human organic anion transporters.

K Y Jung1, M Takeda, D K Kim, A Tojo, S Narikawa, B S Yoo, M Hosoyamada, S H Cha, T Sekine, H Endou.   

Abstract

The purpose of this study was to investigate the characteristics of ochratoxin A (OTA) transport by multispecific human organic anion transporters (hOAT1 and hOAT3, respectively) using the second segment of proximal tubule (S2) cells from mice stably expressing hOAT1 and hOAT3 (S2 hOAT1 and S2 hOAT3). S2 hOAT1 and S2 hOAT3 exhibited a time- and dose-dependent, and a saturable increase in uptake of [3H]-OTA, with apparent Km values of 0.42 microM (hOAT1) and 0.75 microM (hOAT3). These OTA uptakes were inhibited by several substrates for the OATs. Para-aminohippuric acid (PAH), probenecid, piroxicam, octanoate and citrinin inhibited [3H]-OTA uptake by hOAT1 and hOAT3 in a competitive manner (Ki = 4.29-3080 microM), with the following order of potency: probenecid > octanoate > PAH > piroxicam > citrinin for hOAT1; probenecid > piroxicam > octanoate> citrinin > PAH for hOAT3. These results indicate that hOAT1, as well as hOAT3, mediates a high-affinity transport of OTA on the basolateral side of the proximal tubule, but hOAT1- and hOAT3-mediated OTA transport are differently influenced by the substrates for the OATs. These pharmacological characteristics of hOAT1 and hOAT3 may be significantly related with the events in the development of OTA-induced nephrotoxicity in the human kidney.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11669456     DOI: 10.1016/s0024-3205(01)01296-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  18 in total

Review 1.  Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles.

Authors:  Ahsan N Rizwan; Gerhard Burckhardt
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

Review 2.  The organic anion transporter (OAT) family: a systems biology perspective.

Authors:  Sanjay K Nigam; Kevin T Bush; Gleb Martovetsky; Sun-Young Ahn; Henry C Liu; Erin Richard; Vibha Bhatnagar; Wei Wu
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

Review 3.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

4.  Microphysiological system modeling of ochratoxin A-associated nephrotoxicity.

Authors:  Tomoki Imaoka; Jade Yang; Lu Wang; Matthew G McDonald; Zahra Afsharinejad; Theo K Bammler; Kirk Van Ness; Catherine K Yeung; Allan E Rettie; Jonathan Himmelfarb; Edward J Kelly
Journal:  Toxicology       Date:  2020-09-06       Impact factor: 4.221

5.  A role for the organic anion transporter OAT3 in renal creatinine secretion in mice.

Authors:  Volker Vallon; Satish A Eraly; Satish Ramachandra Rao; Maria Gerasimova; Michael Rose; Megha Nagle; Naohiko Anzai; Travis Smith; Kumar Sharma; Sanjay K Nigam; Timo Rieg
Journal:  Am J Physiol Renal Physiol       Date:  2012-02-15

Review 6.  Xenobiotic transporters and kidney injury.

Authors:  Blessy George; Dahea You; Melanie S Joy; Lauren M Aleksunes
Journal:  Adv Drug Deliv Rev       Date:  2017-01-20       Impact factor: 15.470

7.  Modulation of ochratoxin A induced DNA-damage in urothelial cell cultures.

Authors:  G H Degen; S Lebrun; Y Lektarau; W Föllmann
Journal:  Mycotoxin Res       Date:  2005-03       Impact factor: 3.833

8.  Efflux at the Blood-Brain Barrier Reduces the Cerebral Exposure to Ochratoxin A, Ochratoxin α, Citrinin and Dihydrocitrinone.

Authors:  Matthias Behrens; Sabine Hüwel; Hans-Joachim Galla; Hans-Ulrich Humpf
Journal:  Toxins (Basel)       Date:  2021-04-30       Impact factor: 4.546

9.  Lumbar cerebrospinal fluid-to-brain extracellular fluid surrogacy is context-specific: insights from LeiCNS-PK3.0 simulations.

Authors:  Mohammed A A Saleh; Chi Fong Loo; Jeroen Elassaiss-Schaap; Elizabeth C M De Lange
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-06-17       Impact factor: 2.745

10.  Interaction of Natural Dietary and Herbal Anionic Compounds and Flavonoids with Human Organic Anion Transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11).

Authors:  Li Wang; Douglas H Sweet
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-21       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.